Apotheek TANS SRL
Apotheek TANS reported total assets of 110,798 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jun 2026).
The score of Apotheek TANS shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity 0 % Total assets -8 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek TANS's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 71,957 € | ||||
| Equity | 20,372 € | ||||
| Cash | 78,787 € | ||||
| EBITDA | 107,028 € | ||||
| Total assets | 110,798 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jun 2026
- Year ended 31 Dec 2024filed on 07 Jul 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 03 Jul 2023
- Year ended 31 Dec 2021filed on 21 Jun 2022
Apotheek TANS's financial analysis
- Solvency18.4%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek TANS
Apotheek TANS's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0436.374.096
- VAT number
- BE0436374096
- Peppol
- Registered · 0208:0436374096 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Dec 1988
- Registered office
- 3500 Hasselt
- Latest accounts
- 2025 · filed on 15 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek TANS (SRL) has been based in Hasselt since 1988, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 71,957 € and equity of 20,372 €; its revenue is not published. Its solvency stands at 18.4%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apotheek TANS
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie VERHEYDEN Retail sale of pharmaceutical products Brussels · balance sheet 135,673 €
- Grodt Retail sale of pharmaceutical products Uccle · balance sheet 109,794 €
- Selvipharma Retail sale of pharmaceutical products Brussels · balance sheet 109,734 €
- Pharmanou Retail sale of pharmaceutical products Sprimont · balance sheet 112,116 €
- Parapharmacie Discount Braine l'Alleud Retail sale of pharmaceutical products Braine-l'Alleud · balance sheet 113,264 €
- Make A Better Move Retail sale of pharmaceutical products Genappe · balance sheet 114,527 €
- PPPharmacy Retail sale of pharmaceutical products Ghent · balance sheet 106,768 €
- Merckx Retail sale of pharmaceutical products Wichelen · balance sheet 106,701 €
Frequently asked questions about Apotheek TANS
What is the revenue of Apotheek TANS?
Apotheek TANS files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek TANS?
In Belgium, the VAT number is the company number prefixed with BE: BE0436374096 for Apotheek TANS, if the company is VAT-registered. Its company number (CBE) is 0436.374.096.
Where is the registered office of Apotheek TANS?
According to the CBE register, the registered office of Apotheek TANS is in 3500 Hasselt.
What is the equity of Apotheek TANS?
At the close of the 2025 financial year, the equity of Apotheek TANS amounts to 20,372 €, a solvency of 18.4% of total assets.
Who manages Apotheek TANS?
The register lists 1 active mandates at Apotheek TANS. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek TANS
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →